BridgeBio Pharma, Inc. (BBIO)
65.09
+0.05
(+0.08%)
USD |
NASDAQ |
Oct 09, 10:40
BridgeBio Pharma 30-Day Average Daily Volume : 2.697M for Oct. 8, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 08, 2026 | 2.697M |
| October 07, 2026 | 2.642M |
| October 06, 2026 | 2.622M |
| October 05, 2026 | 2.536M |
| October 02, 2026 | 2.521M |
| October 01, 2026 | 2.501M |
| September 30, 2026 | 2.492M |
| September 29, 2026 | 2.489M |
| September 28, 2026 | 2.462M |
| September 25, 2026 | 2.466M |
| September 24, 2026 | 2.439M |
| September 23, 2026 | 2.390M |
| September 22, 2026 | 2.370M |
| September 21, 2026 | 2.342M |
| September 18, 2026 | 2.308M |
| September 17, 2026 | 2.212M |
| September 16, 2026 | 2.215M |
| September 15, 2026 | 2.112M |
| September 14, 2026 | 2.024M |
| September 11, 2026 | 2.034M |
| September 10, 2026 | 2.059M |
| September 09, 2026 | 2.037M |
| September 08, 2026 | 2.032M |
| September 04, 2026 | 2.035M |
| September 03, 2026 | 2.053M |
| Date | Value |
|---|---|
| September 02, 2026 | 2.067M |
| September 01, 2026 | 2.065M |
| August 31, 2026 | 2.063M |
| August 28, 2026 | 2.053M |
| August 27, 2026 | 2.037M |
| August 26, 2026 | 2.120M |
| August 25, 2026 | 2.128M |
| August 24, 2026 | 2.171M |
| August 21, 2026 | 2.246M |
| August 20, 2026 | 2.401M |
| August 19, 2026 | 3.011M |
| August 18, 2026 | 2.970M |
| August 17, 2026 | 2.969M |
| August 14, 2026 | 2.980M |
| August 13, 2026 | 2.983M |
| August 12, 2026 | 3.042M |
| August 11, 2026 | 3.062M |
| August 10, 2026 | 3.068M |
| August 07, 2026 | 3.871M |
| August 06, 2026 | 3.892M |
| August 05, 2026 | 3.991M |
| August 04, 2026 | 3.992M |
| August 03, 2026 | 4.020M |
| July 31, 2026 | 4.102M |
| July 30, 2026 | 4.084M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Alnylam Pharmaceuticals, Inc. | 1.503M |
| Ionis Pharmaceuticals, Inc. | 3.893M |
| Pfizer Inc. | 33.11M |
| BioMarin Pharmaceutical, Inc. | 2.072M |
| Vertex Pharmaceuticals, Inc. | 1.013M |